Biologists have developed the first system for determining gene expression based on machine learning. Considered a type of genetic Rosetta Stone for biologists, the new method leverages algorithms ...

With its collaborators Genentech, Icelandic company DeCode Genetics has found a rare gene variant that marks protection against both Alzheimer's disease and general cognitive decline. This discovery ...

Researchers at the Icelandic biotechnology company DeCode Genetics Incorporated said they found a gene that can double the risk of type 2 diabetes, a disease that affects at least 171 million people ...

LONDON (Reuters) - U.S. biotechnology group Amgen Inc has agreed to buy unlisted Decode Genetics, a pioneer in hunting down genes linked to disease, for $415 million in cash to boost its drive to ...

REYKJAVIK, Iceland, July 18 -- Scientists at deCODE genetics in collaboration with colleagues from Emory University today report the discovery of the first variant in the sequence of the human genome ...

SAN FRANCISCO, California, USA, 8 July 2025 – In a comprehensive Genomic Press Interview published in Brain Medicine, Dr. Michael C. Oldham shares his unconventional journey from advertising executive ...

This issue is preventing our website from loading properly. Please review the following troubleshooting tips or contact us at [email protected]. By submitting your ...

DeCode Genetics Inc. scientists mapped a gene linked to rheumatoid arthritis, a step that could aid development of medicines and diagnostic tests. Rheumatoid arthritis affects about one out of 100 ...

WASHINGTON (Reuters) - Iceland's Decode Genetics Inc, a pioneer in genetic research, has filed for bankruptcy protection, weighed down by debts after 13 years of failing to make a profit. Shares in ...

Dr. Francis Collins is a gene hunter. Early in his career, he found the genes responsible for cystic fibrosis and Huntington’s disease, among others. Then he took over the Human Genome Project, which, ...

LONDON -- Decode Genetics Inc. of Iceland and International Business Machines Corp. announced Thursday a three-year agreement to jointly market Decode's gene-hunting software to other companies.